Cresco Biotech is a biomanufacturing company producing low-carbon biocomposite building materials. By using bacterial mineralization to bind industrial and agricultural waste, they create sustainable alternatives for the construction industry.
Cresco Biotech is a biomanufacturing company that develops low-carbon, sustainable building materials designed to reduce the environmental impact of the construction industry. The company utilizes a proprietary biobinding technology that employs naturally occurring bacteria to grow calcium carbonate crystals, effectively binding agricultural byproducts, natural fibers, and industrial waste aggregates into durable, high-performance construction components at room temperature and pressure. Their manufacturing platform is designed for scalability, enabling the production of versatile, water-resistant, and fire-resistant materials that serve as sustainable alternatives to traditional products like gypsum and cement.
By focusing on circular economy principles, Cresco Biotech transforms waste streams, such as stone fines and hemp hurds, into valuable construction resources, helping builders meet net-zero targets and improve the embodied carbon profile of new infrastructure. Their product portfolio includes specialized lining panels such as the BioCore board, Petrock panel, and BioWich laminate, which provide thermal insulation, acoustic regulation, and breathability for internal applications. These materials are tailored for modern vapour-open construction systems, offering a resilient solution for healthy living environments while simultaneously sequestering carbon within the built environment.